Search CatalystAlert
Search for companies, drugs, and catalysts
Search CatalystAlert
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
2
Regulatory Approvals
No catalyst events have been recorded for this drug yet.
Gefzuris
Treatment of refractory or unexplained chronic cough.
Lyfnua
Lyfnua is indicated in adults for the treatment of refractory or unexplained chronic cough.
View on EMA